Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Falk, E., Circulation, 71 (1985) 699.
Phillips, D.R., Charo, I.F., Parise, L.V. and Fitzgerald, L.A., Blood, 71 (1988) 831.
Ruoslahti, E. and Pierschbacher, M.D., Science, 238 (1987) 491.
Katada, J., Hayashi, Y., Sato, Y., Muramatsu, M., Takiguchi, Y.; Harada, T., Fujiyoshi, T. and Uno, I., J. Biol. Chem., 272 (1997) 7720.
Nicholson, N.S., Panzer-Knodle, S.G., Salyers, A.K., Taite, B.B., Szalony, J.A., Haas, N.F., King, L.W., Zablocki, J.A., Keller, B.T., Broschat, K., Engleman, V.W., Herin, M., Jacqmin, P., Feigen, L.P., Circulation, 91 (1995) 403.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic Publishers
About this chapter
Cite this chapter
Hayashi, Y. et al. (1999). Development of potent non-peptide GPIIb/IIIa antagonists with tri-substituted β-amino acid derivatives as a new conformational restriction unit. In: Shimonishi, Y. (eds) Peptide Science — Present and Future. Springer, Dordrecht. https://doi.org/10.1007/0-306-46864-6_210
Download citation
DOI: https://doi.org/10.1007/0-306-46864-6_210
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-5271-6
Online ISBN: 978-0-306-46864-3
eBook Packages: Springer Book Archive